Dalong Wan

1.6k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Dalong Wan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dalong Wan has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dalong Wan's work include Neuroendocrine Tumor Research Advances (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Lung Cancer Research Studies (5 papers). Dalong Wan is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Lung Cancer Research Studies (5 papers). Dalong Wan collaborates with scholars based in China, Germany and Madagascar. Dalong Wan's co-authors include Shusen Zheng, Jiacheng Huang, Shengzhang Lin, Lin Zhou, Yiting Qiao, Lele Zhang, Wenjie Liang, Lele Zhang, Qiang Huang and Tianye Niu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Dalong Wan

27 papers receiving 1.1k citations

Hit Papers

Extracellular matrix and its therapeutic potential for ca... 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalong Wan China 12 439 280 256 240 185 30 1.1k
Anna Wilkins United Kingdom 16 640 1.5× 340 1.2× 136 0.5× 400 1.7× 137 0.7× 39 1.3k
Vasiliki Bravou Greece 21 324 0.7× 734 2.6× 118 0.5× 210 0.9× 113 0.6× 65 1.2k
Andrew L. Coveler United States 22 1.1k 2.5× 481 1.7× 228 0.9× 244 1.0× 135 0.7× 105 1.7k
Jon Strasser United States 12 228 0.5× 392 1.4× 316 1.2× 167 0.7× 55 0.3× 25 1.2k
Wuhu Zhang China 14 492 1.1× 320 1.1× 56 0.2× 135 0.6× 82 0.4× 38 969
Junhui Sun China 17 174 0.4× 218 0.8× 113 0.4× 196 0.8× 207 1.1× 68 1.1k
Sandra Salvi Italy 23 707 1.6× 473 1.7× 118 0.5× 208 0.9× 96 0.5× 44 1.5k
Yoshiyuki Kobayashi Japan 21 266 0.6× 268 1.0× 80 0.3× 222 0.9× 200 1.1× 54 1.3k
Ethel R. Pereira United States 13 526 1.2× 398 1.4× 49 0.2× 150 0.6× 149 0.8× 17 1.1k
Bonnie L. King United States 19 605 1.4× 465 1.7× 145 0.6× 128 0.5× 152 0.8× 36 1.2k

Countries citing papers authored by Dalong Wan

Since Specialization
Citations

This map shows the geographic impact of Dalong Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalong Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalong Wan more than expected).

Fields of papers citing papers by Dalong Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalong Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalong Wan. The network helps show where Dalong Wan may publish in the future.

Co-authorship network of co-authors of Dalong Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Dalong Wan. A scholar is included among the top collaborators of Dalong Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalong Wan. Dalong Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wan, Dalong, Tingting Qin, Lingfei Guo, et al.. (2025). Risk factors for pelvic organ prolapse in postpartum women: a retrospective cross-sectional study in Southwest China. Frontiers in Medicine. 12. 1663043–1663043.
2.
Zheng, Shusen, et al.. (2024). Alterations in maternal–fetal gut and amniotic fluid microbiota associated with fetal growth restriction. BMC Pregnancy and Childbirth. 24(1). 728–728. 2 indexed citations
3.
4.
Xue, Liang, et al.. (2022). Concomitant hepatocellular carcinoma recurrence and mantle cell lymphoma. Hepatobiliary & pancreatic diseases international. 23(4). 434–437. 1 indexed citations
5.
Huang, Jiacheng, Lele Zhang, Dalong Wan, et al.. (2021). Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduction and Targeted Therapy. 6(1). 580 indexed citations breakdown →
6.
Huang, Jiacheng, Lele Zhang, Jianxiang Chen, et al.. (2021). The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 744951–744951. 12 indexed citations
7.
Chen, Zhitao, Lele Zhang, Jiacheng Huang, et al.. (2021). Targeted-Gene Sequencing and Bioinformatics Analysis of Patients with Pancreatic Mucoepidermoid Carcinoma: A Case Report and Literature Review. OncoTargets and Therapy. Volume 14. 3567–3581. 3 indexed citations
8.
Chen, Zhitao, et al.. (2021). Inflammatory myofibroblastic tumor of the pancreatic neck: A case report and review of literature. World Journal of Clinical Cases. 9(22). 6418–6427. 5 indexed citations
9.
Huang, Jiacheng, et al.. (2021). Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Frontiers in Oncology. 11. 711402–711402. 20 indexed citations
10.
Liang, Wenjie, et al.. (2020). Differentiating Hepatic Epithelioid Angiomyolipoma From Hepatocellular Carcinoma and Focal Nodular Hyperplasia via Radiomics Models. Frontiers in Oncology. 10. 564307–564307. 21 indexed citations
11.
Li, Mengxia, Qiyong Li, Min Xiao, et al.. (2019). Survival comparison between primary hepatic neuroendocrine neoplasms and primary pancreatic neuroendocrine neoplasms and the analysis on prognosis-related factors. Hepatobiliary & pancreatic diseases international. 18(6). 538–545. 12 indexed citations
12.
Liang, Wenjie, Pengfei Yang, Rui Huang, et al.. (2018). A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clinical Cancer Research. 25(2). 584–594. 150 indexed citations
13.
Zhang, Liang, Dalong Wan, Li Bao, et al.. (2018). Neuroendocrine carcinoma in the extrahepatic biliary tract. Medicine. 97(29). e11487–e11487. 10 indexed citations
14.
Liang, Wenjie, Lei Xu, Pengfei Yang, et al.. (2018). Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma. Frontiers in Oncology. 8. 360–360. 91 indexed citations
15.
Xuan, Zefeng, Jian Chen, Penghong Song, et al.. (2018). Management of intrahepatic splenosis:a case report and review of the literature. World Journal of Surgical Oncology. 16(1). 119–119. 14 indexed citations
16.
Wang, Bei, et al.. (2018). Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer. Biochemical and Biophysical Research Communications. 499(2). 156–163. 32 indexed citations
18.
Wan, Dalong, et al.. (2016). Liver Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review. Transplantation Proceedings. 48(9). 3197–3202. 1 indexed citations
19.
Wang, Bei, et al.. (2016). Carcinosarcoma of the Lesser Omentum. Medicine. 95(14). e3246–e3246. 6 indexed citations
20.
Wan, Dalong, et al.. (2016). Hepatic schwannoma: A case report and an updated 40-year review of the literature yielding 30 cases. Molecular and Clinical Oncology. 4(6). 959–964. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026